SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ore Pharmaceuticals Inc. -- Ignore unavailable to you. Want to Upgrade?


To: Mike McFarland who wrote (36)9/11/2009 12:20:18 PM
From: Mike McFarlandRead Replies (1) | Respond to of 50
 
Presentation slides, and a letter to shareholders
are available through the orxe website.
orepharma.com

Orxe also issued a PR announcing an article in the online
journal Inflammation Research “Effects of the ACE2
inhibitor GL1001 on acute dextran sodium sulfate-induced
colitis in mice”
phx.corporate-ir.net